Higher proportions of women eligible for breast conservation surgery (BCS) are undergoing mastectomy, breast reconstruction and bilateral mastectomy, with large increases seen in women with lymph node-negative and in situ disease, according to a report published online by JAMA Surgery.
The cure rates for early-stage colon and rectal cancers can be over 90 per cent. In Europe and the US these are among the most common of cancers.
Within the next 10 to 15 years, three-quarters of patients with colorectal cancer can be expected to survive five years or longer – a huge jump in a relatively short period, Gary Culliton reports in his latest Clinical Update.
Patients have a range of options available to them before and following chemotherapy, a meeting of European experts has heard. Michelle McDonagh reports.
Endocrine treatments are directed at patients who express the oestrogen receptor. In around 75 percent of breast cancers, oestrogen encourages them to grow. This type of breast cancer can be treated with drugs such as tamoxifen but many people develop resistance and see their breast cancer return.
There is a good chance that intermediate-risk breast cancer patients will not get chemotherapy in future, Gary Culliton reports in his latest Clinical Update. However, high-risk patients, who will benefit from chemotherapy, will get it.
Researchers at Queen’s University have made a significant breakthrough that may benefit patients with bowel cancer.
A wild berry native to North America may strengthen the effectiveness of a chemotherapy drug commonly used to treat pancreatic cancer, reveals experimental research published online in the Journal of Clinical Pathology.
The development of the first alpha-emitting radionuclide is set to usher in a new era in prostate cancer treatment. Dawn O’Shea spoke to UCD graduate and Belfast oncologist Prof Joe O’Sullivan who was one of the lead investigators involved in developing the new ground-breaking therapy.
Photodynamic therapy (PDT), which uses topical agents and light to kill tissue, appears to better clear actinic keratoses (AKs), a common skin lesion caused by sun damage, at three months after treatment than cryotherapy